Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Healing & Recovery
Gastric pentadecapeptide with broad tissue-healing properties.
Peptide B
Cosmetic
Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties.
Typical vial
5 mg
Typical dose
250-500 mcg
Half-life
~4 hours (estimated from animal pharmacokinetic data)
FDA status
Not FDA approved for human use. FDA issued a warning letter …
Typical vial
50 mg
Typical dose
200-500 mcg
Half-life
~30-60 minutes (plasma)
FDA status
Not FDA approved as a drug. Widely used as a cosmetic ingred…
BPC-157 effects
GHK-Cu effects
BPC-157 side effects
GHK-Cu side effects
BPC-157 dosing ranges
General tissue repair
250-500 mcg · Once or twice daily · 4-6 weeks
Gut healing
250-500 mcg · Twice daily (oral or SubQ) · 4-8 weeks
Acute injury recovery
500 mcg · Twice daily near injury site · 2-4 weeks
GHK-Cu dosing ranges
Skin rejuvenation (topical)
1-2% concentration · Once or twice daily · Ongoing
Systemic tissue support (SubQ)
200-500 mcg · Once daily · 4-6 weeks
Wound healing support (SubQ)
200-500 mcg · Once daily near wound site · 2-4 weeks
BPC-157: Gastric pentadecapeptide with broad tissue-healing properties. Typical dose 250-500 mcg. GHK-Cu: Copper-binding tripeptide with potent wound-healing, skin-remodeling, and gene-regulatory properties. Typical dose 200-500 mcg. Both fall under the Healing & Recovery and Cosmetic categories.
Stacking BPC-157 with GHK-Cu is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
BPC-157 is typically dosed: Once or twice daily for General tissue repair; Twice daily (oral or SubQ) for Gut healing; Twice daily near injury site for Acute injury recovery. GHK-Cu is typically dosed: Once or twice daily for Skin rejuvenation (topical); Once daily for Systemic tissue support (SubQ); Once daily near wound site for Wound healing support (SubQ).
BPC-157: Not FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products. GHK-Cu: Not FDA approved as a drug. Widely used as a cosmetic ingredient without requiring drug approval for topical formulations.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free